Android app on Google Play

Array Biopharma, Inc. (ARRY) Tops Q2 EPS by 4c

February 4, 2013 4:46 PM EST Send to a Friend
Array Biopharma, Inc. (NASDAQ: ARRY) reported Q2 EPS of ($0.10), $0.04 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $18.4 million versus the consensus estimate of $16.52 million.

For earnings history and earnings-related data on Array Biopharma, Inc. (ARRY) click here.




You May Also Be Interested In


Related Categories

Earnings

Related Entities

Earnings

Add Your Comment